Query: stroke

Filtered By:
Management: National Institute for Health and Clinical Excelle

This page shows you your search results in order of relevance.

Order by Relevance | Date

Total 126 results found since Jan 2013.

Prognostic factors for patients with acute ischemic stroke treated by mechanical thrombectomy
【Background and Purpose】To elucidate the prognostic factors for mechanical thrombectomy (MT), we investigated (retrospectively) a series of patients with acute ischemic stroke (AIS) treated with MT in our hospital.
Source: Journal of Stroke and Cerebrovascular Diseases - March 18, 2017 Category: Neurology Authors: Katsuharu Kameda, Junji Uno, Shota Yoshida, Ryosuke Otsuji, Nice Ren, Shintaro Nagaoka, Kazushi Maeda, Yoshiaki Ikai, Hidefuku Gi Source Type: research

NICE issues final appraisal determination on apixaban for prevention of stroke and systemic embolism in non-valvular atrial fibrillation
Source: NICE Area: News In its final appraisal determination (FAD), NICE has supported the use of apixaban as an option for preventing stroke and systemic embolism within its marketing authorisation, that is, in people with nonvalvular atrial fibrillation with one or more risk factors (prior stroke or ischaemic attack, age 75 years or older, hypertension, diabetes mellitus or symptomatic heart failure).   The appeal period for this appraisal will close on 6 February 2013.
Source: NeLM - Cardiovascular Medicine - January 23, 2013 Category: Cardiology Source Type: news

NICE backs drug to reduce stroke risk for AF patients
The National Institute for Clinical Excellence is now recommending the use of apixaban for some patients with irregular heartbeats to help prevent them experiencing stroke or systemic embolism.
Source: Nursing Times Breaking News - January 23, 2013 Category: Nursing Source Type: news

Pfizer anti-stroke drug apixaban now available on UK NHS
The UK's National Institute for Health and Clinical Excellence (NICE) has announced it is now recommending NHS doctors in England and Wales prescribe new drug apixaban for the prevention of stroke.
Source: Pharmaceutical Technology - January 23, 2013 Category: Pharmaceuticals Source Type: news

NICE costing statement for its guidance on apixaban for prevention of stroke and systemic embolism in non-valvular atrial fibrillation (TA 275)
Source: NICE Area: News NICE has published a costing statement to accompany its guidance on the use of apixaban for preventing stroke and systemic embolism in nonvalvular atrial fibrillation (TA 275).   The statement notes that "Apixaban provides an alternative treatment option at a comparable cost and therefore it is anticipated that there will not be a significant cost impact as a result of implementing this guidance."
Source: NeLM - Cardiovascular Medicine - February 27, 2013 Category: Cardiology Source Type: news

NICE issues final guidance supporting the use of apixaban for prevention of stroke and systemic embolism in non-valvular atrial fibrillation (TA 275)
Source: NICE Area: Evidence > Guidelines NICE has issued final guidance (TA 275) supporting the use of apixaban as an option for preventing stroke and systemic embolism within its marketing authorisation, that is, in people with nonvalvular atrial fibrillation with 1 or more risk factors such as:   . prior stroke or transient ischaemic attack . age 75 years or older . hypertension . diabetes mellitus . symptomatic heart failure.   NICE notes that the decision about whether to start treatment with apixaban should be made after an informed discussion between the clinici...
Source: NeLM - Cardiovascular Medicine - February 27, 2013 Category: Cardiology Source Type: news

NICE issues first guidelines on stroke rehabilitation
'Joined-up' care essential say expertsRelated items from OnMedicaSpecialist stroke support costs NHS lessStroke therapists must offer seven-day workingEmotional support for stroke survivors is inadequateStroke survival best in specialist unitsTreatment is faster in high volume stroke centres
Source: OnMedica Latest News - June 12, 2013 Category: UK Health Source Type: news

Joined-up working required for effective stroke rehab services
Stroke is a major health problem in the UK. Each year an estimated 150,000 people have a stroke - equivalent to one person every five minutes. In its first clinical guideline on stroke rehabilitation, NICE says that people with disability after stroke should receive rehabilitation in a dedicated stroke inpatient unit, and subsequently from a specialist stroke team within the community.
Source: NHS Networks - June 20, 2013 Category: UK Health Authors: Maria Axford Source Type: news

National Institute for Health and Care Excellence stroke rehabilitation guidance - is it useful, usable, and based on best evidence?
Abstract In the UK, the National Institute for Health and Care Excellence (NICE) is responsible for producing clinical guidance based on sound evidence. In 2013 they produced guidance on Stroke Rehabilitation and this editorial outlines why this is not a useful guide for clinicians or commissioners. Primarily this is because NICE used inappropriate methods; the methods used are appropriate for evaluating drugs, but are inappropriate when applied to any complex intervention. Moreover, the actual recommendations are written in clinically unhelpful language. Future rehabilitation guidance should include ensuring that...
Source: Clinical Rehabilitation - May 23, 2014 Category: Rehabilitation Authors: Drummond A, Wade DT Tags: Clin Rehabil Source Type: research

NICE advises against aspirin for cutting stroke risk in AF patients
The National Institute for Health and Care Excellence has recommended that people with atrial fibrillation are prescribed an anticoagulant instead of aspirin to reduce their risk of stroke.
Source: Nursing Times Breaking News - June 20, 2014 Category: Nursing Source Type: news

The Move Towards Full Implementation Of The Nice Guidelines For Stroke Prevention In Atrial Fibrillation: The Potential Cost And Clinical Impact
Updated treatment guidelines for atrial fibrillation (AF) have been released by the National Institute for Health and Care Excellence (NICE) in the United Kingdom and highlight a current shortfall in the prescribing of anticoagulants to patients with AF despite the importance of stroke prevention. A model was designed for use as a planning tool for Clinical Commissioning Groups (CCGs) looking to budget for the future move towards full implementation of the NICE guidelines.
Source: Value in Health - November 1, 2014 Category: Global & Universal Authors: G.E. Shields, A.M. Chapman Source Type: research

Losing And Finding My Mother After Her Stroke
The air outside a hospital feels especially cool and fresh. The natural light, even if it's gray January light is a blessed relief after the fluorescent tunnels I've been guiding my mother along. We had a funny moment of intimacy in the bathroom, trying to get her urine sample in a cup. It isn't easy: crouching, aiming, approximating where in the space below you the stream will collect. Add a daughter trying to micromanage her mother's urine flow and a line of weak-bladdered patients queuing outside, rolling their eyes and tugging at their waistbands and you have all the ingredients of a Mike and Elaine sketch. Sometimes...
Source: Healthy Living - The Huffington Post - March 19, 2015 Category: Consumer Health News Source Type: news

Aspirin too risky for stroke patients, NICE says
Adults with atrial fibrillation (AF) should no longer be prescribed aspirin to prevent stroke, NICE guidance released today said Hide related content:  Show related content read more
Source: Management in Practice - July 10, 2015 Category: Practice Management Authors: ltrevallion Tags: *** Editor ' s Pick Latest News Source Type: news

NICE recommends anticoagulants over aspirin for stroke prevention
AF is a condition that affects the heart, causing it to beat irregularly and too fast. When this happens, blood does not flow properly through the heart and the rest of the body. NICE’s latest quality standard, which sets out advice on the treatment and management of AF,  recommends that people with AF who have a CHA2DS2-VASC stroke risk score of 2 or above are offered newer anticoagulants, such as apixaban, dabigatran etexilate, rivaroxaban or a vitamin K antagonist like warfarin.
Source: NHS Networks - July 10, 2015 Category: UK Health Authors: Maria Axford Source Type: news

Correspondence The future of stroke therapy must not be mired by past arguments
Stroke is the leading cause of disability and the fifth leading cause of death in the UK, costing the UK economy more than £7 billion per year.1 At present, the only therapeutic approved by the UK National Institute for Health and Care Excellence (NICE) for the treatment of ischaemic stroke is thrombolysis using recombinant tissue-type plasminogen activator (rtPA). However, rtPA is only effective in patients who present within 4·5 h of stroke onset, with a number needed to treat for benefit of 3·6 before 90 min, rising to 5·9 between 3 h and 4·5 h.
Source: LANCET - August 14, 2015 Category: Journals (General) Authors: Alastair M Buchan, Hasneen G Karbalai, Brad A Sutherland Tags: Correspondence Source Type: research

NICE recommends treatment with alteplase is started as early as possible, within 4.5 hours of onset of ischaemic stroke symptoms
Source: Boehringer Ingelheim Corporate News - July 25, 2016 Category: Research Source Type: news

Scan suspected stroke patients within 1 hour, says RCP
Royal College of Physicians launches new guidance Related items fromOnMedica Stroke patients still not getting care they need NHS stroke care getting better NICE wants GPs to prevent 8,000 strokes a year Aspirin after mini-stroke reduces risk of major stroke Stroke can often be avoided, claims study
Source: OnMedica Latest News - October 4, 2016 Category: UK Health Source Type: news

Make sure that 'funny turn' does not become a STROKE: Thousands who suffer dizziness and blurred vision are denied the preventative treatment that could save their lives
The National Institute for Health and Clinical Excellence (NICE) recommends that anyone who has a mini stroke should have an operation to clear the carotid artery within two weeks.
Source: the Mail online | Health - December 6, 2016 Category: Consumer Health News Source Type: news

Make sure that 'funny turn' does not become a STROKE
The National Institute for Health and Clinical Excellence (NICE) recommends that anyone who has a mini stroke should have an operation to clear the carotid artery within two weeks.
Source: the Mail online | Health - December 6, 2016 Category: Consumer Health News Source Type: news

Marital history linked to stroke survival
Stroke survival is highest for married people who have never been divorced or widowed Related items fromOnMedica Depression risk much higher for three months after stroke RCGP defends ‘under-prescription’ of stroke medicines by GPs Lifestyle factors biggest cause of heart disease risk variation NICE wants GPs to prevent 8,000 strokes a year Stroke can often be avoided, claims study
Source: OnMedica Latest News - December 14, 2016 Category: UK Health Source Type: news

National Survey of Neurosurgeons and Stroke Physicians on Decompressive Hemicraniectomy for Malignant Middle Cerebral Artery Infarction
Several studies have evaluated the use of decompressive hemicraniectomy (DHC) in malignant middle cerebral artery infarction (MMCAI). In the United Kingdom (UK), the National Institute for Health and Care Excellence (NICE) has set criteria for selection of patients for DHC in MMCAI. We set out to survey the attitudes and practice of neurosurgeons and stroke physicians within the UK towards DHC in MMCAI.
Source: World Neurosurgery - February 20, 2017 Category: Neurosurgery Authors: Pallavi Basu, Harri Jenkins, Kevin Tsang, Vejay N. Vakharia Tags: Original article Source Type: research

115 Anticoagulation in atrial fibrillation – a single-centre audit on patient education, stroke and bleeding risk assessments and use of direct oral anticoagulants (DOACs)
Objective: To assess adherence to the National Institute of Health and Care Excellence (NICE) guidelines on management of atrial fibrillation in adults, specifically the provision of a personalised package of care and information to patients, and stroke and bleeding risk assessments. To assess the frequency of use of DOACs as the anticoagulant of choice.
Source: Europace - October 5, 2017 Category: Cardiology Source Type: research

A Business Case For Stroke Reduction Initiatives In Atrial Fibrillation: 3-Year Financial Projections For Three UK Regions
Atrial Fibrillation (AF) is a common and treatable risk factor for ischaemic stroke and vascular dementia with rising incidence. Oral anticoagulation (OAC) therapy is a well-evidenced way to prevent AF-related strokes, as supported by NICE Clinical Guidelines (CG180, 2014).
Source: Value in Health - October 1, 2017 Category: International Medicine & Public Health Authors: A Orlowski, T Jamieson, J Belsey, R Slater, J Macdonald Source Type: research

89implementing evidence based practice: an audit of intermittent pneumatic compression (ipc) prescription in stroke at a district stroke centre
Introduction: The CLOTS III randomised control trail demonstrated that “IPC is an effective and inexpensive method of reducing the risk of DVT and improving survival in immobile stroke patients.”1. DVT risk is highest amongst stroke patients following immobilisation and NICE (CG 92) recommends application of IPC devices and documentation of a decision for or against them in this high risk patient group.
Source: Age and Ageing - March 27, 2018 Category: Geriatrics Source Type: research

Thrombectomy to be offered up to 24h after onset of stroke
NICE recommends procedure in new draft guideline Related items fromOnMedica Stroke survivors need more help taking medicine Stroke deaths falling in Europe, overall Diagnosing a transient ischaemic attack One in two women and one in three men will develop neurological disease Having a stroke doubles dementia risk
Source: OnMedica Latest News - November 26, 2018 Category: UK Health Source Type: news

Stroke survivors face high risk of visual problems
Up to six in 10 stroke survivors experience new visual problems prompted by their stroke Related items fromOnMedica Loneliness itself appears not to raise risk of heart attack/stroke NICE wants GPs to prevent 8,000 strokes a year Regular GP pulse checks of elderly patients could prevent strokes, study finds Experts warn of heart risks for people with diabetes Wait and hip measurement better indicator of heart attack risk than obesity
Source: OnMedica Latest News - March 11, 2019 Category: UK Health Source Type: news

The role of interventional neuroradiology in treatment of hemorrhagic stroke.
Abstract Treatment of hemorrhagic strokes necessitates hospitalization in an accommodated hospital offering the possibility of a multidisciplinary approach. In this setting, over recent years interventional radiology has become increasingly important from the diagnostic as well as the therapeutic standpoint. In the context of subarachnoid hemorrhage by intracranial aneurysm rupture, the NICE (National Institute for Health and Clinical Excellence) and ASA (American Stroke Academy) recommendations suggest that endovascular coiling should be considered as an alternative to surgical clipping (class I, level of evidenc...
Source: Presse Medicale - May 29, 2019 Category: General Medicine Authors: Michelozzi C, Cognard C Tags: Presse Med Source Type: research

Low cholesterol may increase risk for hemorrhagic stroke
LDL cholesterol levels below 70 mg/dL linked to higher risk of haemorrhagic stroke Related items fromOnMedica NICE issues guidelines on neurological conditions Stroke patients still not getting care they need Vitamin D supplements do not confer cardiovascular protection Physical activity might offset harms of time spent sitting Recurrent stroke more likely at very low BP
Source: OnMedica Latest News - July 2, 2019 Category: UK Health Source Type: news

Low cholesterol may increase risk for haemorrhagic stroke
LDL cholesterol levels below 70 mg/dL linked to higher risk of haemorrhagic stroke Related items fromOnMedica NICE issues guidelines on neurological conditions Stroke patients still not getting care they need Vitamin D supplements do not confer cardiovascular protection Physical activity might offset harms of time spent sitting Recurrent stroke more likely at very low BP
Source: OnMedica Latest News - July 2, 2019 Category: UK Health Source Type: news

New guidelines should benefit stroke patients
An NHS workforce and resource impact statement highlights the work being done to make changes recommended by NICE in its updated stroke guideline part of routine NHS patient care.
Source: NHS Networks - July 18, 2019 Category: UK Health Source Type: news

Innovative stroke detection monitor given green light
Implant could prevent hundreds of strokes, says NICE Related items fromOnMedica Stroke can often be avoided, claims study Public campaign has resulted in 4000 fewer people disabled by stroke Dementia and stroke funding remains too low, say experts Stroke patients still not getting care they need AF screening with smartphone cheap and feasible
Source: OnMedica Latest News - January 13, 2020 Category: UK Health Source Type: news

NICE consults on potential new QOF indicators for 2014/15
Source: NICE Area: News NICE is inviting comment from stakeholders on 14 potential new indicators for consideration for the 2014/15 Quality and Outcomes Framework (QOF), covering the following topics:   . Hypertension . Dementia . Coronary heart disease . Diabetes (including tightly linked measures) . Peripheral arterial disease . Stroke and TIA   The consultation will close at 5pm on 4th February 2013.
Source: NeLM - News - January 7, 2013 Category: Drugs & Pharmacology Source Type: news

NHS Evidence expert commentary: Benefits of drug therapy are unclear for mild hypertension
Source: NHS Evidence Area: News The January edition of 'Eyes on Evidence', the free monthly e-bulletin from NHS Evidence covering major new published evidence as it emerges with an explanation about what it means for current practice, includes an expert commentary on new data from a Cochrane review that aimed to quantify the effects of antihypertensive drug therapy versus no treatment on mortality and morbidity in adults with mild hypertension and no evidence of cardiovascular disease. It included four RCTs with 8912 participants. The review concluded that, compared with placebo, antihypertensive treatment does not reduce...
Source: NeLM - Cardiovascular Medicine - January 10, 2013 Category: Cardiology Source Type: news

Doctors urged to use a new blood pressure test to predict the risk of patients having a stroke
The National Institute for Health and Clinical Excellence (Nice) said if doctors suspect a patient has high blood pressure, they should use the WatchBP Home A device which could ‘opportunistically’ detect atrial fibrillation.
Source: the Mail online | Health - January 16, 2013 Category: Consumer Health News Source Type: news

Watchdog Backs AF Blood Pressure Device
Detection and treatment of dangerous atrial fibrillation is vital A new blood pressure measuring device that can also detect a dangerous heart condition has been backed by the health watchdog. New guidance from the National Institute for Clinical Excellence (NICE) supports the use of the 'WatchBP Home A' device by healthcare professionals in primary care to opportunistically detect atrial fibrillation (AF) during measurement of blood pressure. AF is one of the most common types of abnormal heart rhythm and a major cause of stroke if left untreated...
Source: Health News from Medical News Today - January 18, 2013 Category: Consumer Health News Tags: Hypertension Source Type: news

NICE guidance supports new blood pressure device that can detect atrial fibrillation
The guidance backs use of WatchBP Home A, which could reduce the incidence of atrial fibrillation-related stroke by improving early detection. The guidance also recommends that WatchBP Home A should be considered for use in people with suspected hypertension (high blood pressure) or those being screened for hypertension in primary care.
Source: NHS Networks - January 21, 2013 Category: UK Health Authors: Maria Axford Source Type: news

NICE Final Appraisal Determination on ELIQUIS®
Bristol-Myers Squibb and Pfizer Ltd. have announced that the National Institute for Health and Clinical Excellence (NICE) has issued a fast-tracked Final Appraisal Determination (FAD) recommending the oral anticoagulant Eliquis (apixaban) as an option for preventing stroke and systemic embolism, in patients with non-valvular atrial fibrillation (AF) with one or more risk factors.
Source: Pharmacy Europe - January 24, 2013 Category: Drugs & Pharmacology Source Type: news

Lucy Mangan: wanted – mother for Neanderthal baby
'Don't you long, occasionally, for something really, really interesting, something different, something overwhelmingly "other" to happen?'It's possible that the snow has driven me stir crazy. Although, as someone who, when under stress, still draws diagrams of the underground, Womble burrow-based home that she plans to build when she wins the lottery, I think that is highly unlikely. In any case, I have been seized by the idea of having another baby.Not just any old baby – I've already got one of those – but a Neanderthal baby. Earlier this week Professor George Church, a genetic researcher at Harva...
Source: Guardian Unlimited Science - January 26, 2013 Category: Science Authors: Lucy Mangan Tags: The Guardian Family Genetics Evolution Biology Parents and parenting Anthropology Features Life and style Neanderthal man Science Source Type: news

InFocus: Plans to Streamline Stroke Research in the Works
HONOLULU (MedPage Today) -- Wouldn't it be nice if a clinical trial took only months to initiate rather than years? The NIH thinks so too and has a plan to make that dream come true, deputy director Walter Koroshetz, MD, said in this exclusive InFocus interview.
Source: MedPage Today Cardiovascular - February 11, 2013 Category: Cardiology Source Type: news

New stroke prevention treatment recommended by NICE
Atrial fibrillation (AF) is the most common cause of irregular heart beat. It can cause the heart rhythm to become disorganised, and on occasion too fast, leading to the inefficient pumping of blood around the body.
Source: NHS Networks - February 28, 2013 Category: UK Health Authors: Karen Topping Source Type: news

Supporting the commissioning of anticoagulation therapy for adults
This resource supports commissioners to review how anticoagulation therapy is currently initiated, provided, monitored and reviewed in their local area with particular consideration to the introduction of the novel oral anticoagulants. NICE recommendations for rivaroxaban, dabigatran and apixaban for stroke prevention in people with atrial fibrillation and rivaroxaban for treatment of deep vein thrombosis provide people who have these conditions with more choices of medication. This will have an impact on the commissioning of anticoagulation services at a local level, with an anticipated reduction in vitamin K antagonist monitoring services.
Source: NHS Networks - May 23, 2013 Category: UK Health Authors: Maria Axford Source Type: news

Drugs to be offered to women at high risk of breast cancer
The National Institute of Health and Care Excellence (NICE) has today released updated guidelines on the care of women who are at increased risk of breast cancer due to their family history. One of the main changes to the original guidance from 2004 is that NICE now recommends drug treatment with tamoxifen or raloxifene to reduce risk of breast cancer in a specific group of women who are at high risk of breast cancer and have not had the disease. They say that these treatments could help prevent breast cancer in about 488,000 women aged 35 years and older. The updated guideline has also made changes to the recommende...
Source: NHS News Feed - June 25, 2013 Category: Consumer Health News Tags: Cancer Medical practice QA articles Source Type: news

Why acupuncture is giving sceptics the needle
Acupuncture has been prescribed by half of Britain's doctors, but after 3,000 clinical trials its efficacy remains unproven. So is the NHS making a grave error in supporting this ancient treatment?• Are vitamin pills a sham? Q&A with Dr. Paul OffitYou can't get crystal healing on the NHS. The Department of Health doesn't fund faith healing. And most doctors believe magnets are best stuck on fridges, not patients. But ask for a treatment in which an expert examines your tongue, smells your skin and tries to unblock the flow of life force running through your body with needles and the NHS will be happy to oblige.The govern...
Source: Guardian Unlimited Science - July 26, 2013 Category: Science Authors: David Derbyshire Tags: Culture Health Science and scepticism Features NHS Alternative medicine The Observer Source Type: news

Heparin, grad students, a clinical revolution and giving credit where it's due
The story of a grad student who overcame remarkable odds only to be denied his moment of glory, or a tale of dark deceit and devilish doings? The story of heparin is as complicated as the chemistry itselfBlood is remarkable.A liquid that carries nutrients, waste products and the ever-vigilant cells of the immune system around the body, blood rapidly turns into a solid when it leaves its veins and arteries and becomes exposed to bodily tissues or the air outside. This process of solidification – clotting, or coagulation – is executed and controlled by a complex set of reactions and interactions primarily involving the e...
Source: Guardian Unlimited Science - September 4, 2013 Category: Science Authors: Richard P Grant Tags: theguardian.com Blogposts Science Source Type: news

Euro launch of next-gen thrombectomy device announced
The European launch of a next-generation clot-removal device offering enhanced navigation through the cerebral vasculature and rapid restoration of blood flow to the brain after an ischemic stroke was announced this month at the 5th Congress of European Society of Minimally Invasive Neurological Therapy (ESMINT) in Nice, Italy. The Revive SE Thrombectomy device is by Codman Neuro, part of DePuy Synthes Companies of Johnson & Johnson. read more
Source: Articles from MedicalDesign.com - September 16, 2013 Category: Medical Equipment Tags: Business Cardiovascular Source Type: news

Walking ‘could save 37,000 lives a year’ report claims
The benefits of walking have been reported across the UK media. The BBC reports that “walking more 'would save thousands' of lives in the UK”. These stories have been prompted by the "Walking Works” report (PDF, 3.4MB). It provides an overview of current evidence on physical inactivity, and makes the case for encouraging more people to take up walking as a form of physical activity. It lays out that a large proportion of the population is not meeting physical activity guidelines and that if more people did so, this could potentially save 37,000 lives a year in England. It also discusses the specific benefits o...
Source: NHS News Feed - October 7, 2013 Category: Consumer Health News Tags: Cancer Lifestyle/exercise QA articles Source Type: news

Should I take statins?
Since 80% of cardiovascular disease is caused by lack of exercise, poor diet and smoking, it would be better to address these factors rather than pop a statinShould everyone over 50 be taking statins? asked an editorial in the Lancet last year. No, said an analysis article in last week's BMJ. Statins, in case you've escaped the hype, are drugs that block an enzyme in the liver that's needed to make cholesterol (we make it as well as eat it). Statins reduce levels of low density lipoproteins – the bad cholesterol that furs up arteries and can cause heart disease. But is there any benefit in taking a statin if yo...
Source: Guardian Unlimited Science - October 27, 2013 Category: Science Authors: Luisa Dillner Tags: The Guardian Medical research Health & wellbeing Human biology Drugs Features Life and style Science Source Type: news

Healthy BMI? 8M Britons at high risk of heart disease and diabetes despite 'normal' reading
People of African, Caribbean and Asian descent are up to six times more likely to suffer from type 2 diabetes, heart disease and stroke, NICE has warned.
Source: the Mail online | Health - January 22, 2014 Category: Consumer Health News Source Type: news

NICE publishes new draft guidelines on statins use
"Millions more people should be put on cholesterol-lowering statin drugs," BBC News reports. Draft guidance from the National Institute for Health and Care Excellence (NICE) has recommended that the drugs should be given to people with an estimated 1 in 10 or more risk of cardiovascular disease (CVD), which includes conditions such as heart disease and stroke. Statins are medicines that can help lower rates of low-density lipoprotein (LDL) cholesterol (so-called "bad" cholesterol) in the blood. High rates of LDL cholesterol can lead to hardening of the arteries, a risk factor for CVDs. At present,...
Source: NHS News Feed - February 12, 2014 Category: Consumer Health News Tags: Heart/lungs Medication QA articles Source Type: news

Resistant hypertension: resistance to treatment or resistance to taking treatment?
The treatment of hypertension has been a therapeutic success. A generation or more of effective drugs deserves considerable credit for their contribution to the substantial decline in age-related incidence of stroke, ischaemic heart disease and heart failure. And because almost all the drugs are long-since off patent, the cost of success comes cheaply. Indeed, National Institute of Health and Care Excellence (NICE) has branded treatment of hypertension as not only cost effective but cost saving.1 Yet not all patients achieve their blood pressure target and are labelled as ‘resistant hypertension’. A contentious...
Source: Heart - May 8, 2014 Category: Cardiology Authors: Brown, M. J. Tags: Drugs: cardiovascular system, Hypertension, Interventional cardiology, Epidemiology Editorials Source Type: research